Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Biotech
Vertex drops Moderna-partnered inhaled CF candidate
Persistent lung inflammation issues doomed a next-gen cystic fibrosis candidate that was meant to help a group of patients not served by current meds.
Darren Incorvaia
May 4, 2026 5:48pm
Trump met with Makary before FDA’s Moderna walkback: report
Feb 19, 2026 11:30am
FDA accepts filing for Moderna flu vaccine after swift rethink
Feb 18, 2026 9:21am
Fierce Pharma
Vaccine makers facing increased volatility, uncertainty at FDA
Feb 13, 2026 11:12am
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
HHS stands behind FDA decision to spurn Moderna flu filing
Feb 11, 2026 3:13pm